Symbols / CSBR $6.01 +3.62% Champions Oncology, Inc.

Healthcare • Biotechnology • United States • NCM
CSBR Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 83.46M Enterprise Value 81.43M Income -2.34M Sales 57.95M Book/sh 0.31 Cash/sh 0.51
Dividend Yield Payout 0.00% Employees 213 IPO P/E 34.71 Forward P/E 60.10
PEG P/S 1.44 P/B 19.51 P/C EV/EBITDA -105.48 EV/Sales 1.41
Quick Ratio 0.93 Current Ratio 0.98 Debt/Eq 114.19 LT Debt/Eq EPS (ttm) -0.18 EPS next Y 0.10
EPS Growth Revenue Growth -2.80% Earnings 2026-03-12 ROA -4.70% ROE -47.59% ROIC
Gross Margin 45.88% Oper. Margin -1.13% Profit Margin -4.04% Shs Outstand 13.89M Shs Float 5.19M Short Float 1.20%
Short Ratio 8.73 Short Interest 52W High 9.63 52W Low 5.50 Beta 0.40 Avg Volume 7.82K
Volume 8.26K Target Price Recom None Prev Close $5.80 Price $6.01 Change 3.62%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$6.10
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest CSBR news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-30 ACKERMAN JOEL Director 94,405 $2.10 $198,250
2024-10-31 ACKERMAN JOEL Director 105,137 $2.10 $276,289
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category